NCT05008523

Brief Summary

Overdose deaths are currently the largest cause of accidental death in the US and opioid-related overdose deaths constitute the overwhelming majority of these deaths. Demands for a knowledge-base for effective law enforcement interventions is growing. This proposed study is designed to provide a knowledge base regarding key obstacles and facilitators of the willingness and preparedness of police to administer naloxone and related risk reduction practices and evaluate the efficacy of a web-based opioid-related occupational safety and risk reduction curriculum. Findings from this study will be applied to the development and implementation of effective interventions for police officers aimed at harmonizing law enforcement practices with public health goals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
333

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 22, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 17, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

December 7, 2023

Status Verified

March 1, 2023

Enrollment Period

2.1 years

First QC Date

June 21, 2021

Last Update Submit

November 30, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in Naloxone Behavioral Outcomes in Policing Procedure

    Number of days during the past 30 days in which participants had naloxone available and carried naloxone while at work.

    Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in Naloxone Behavioral Outcomes in Policing Procedure

    Number of days during the past 30 days in which participants had naloxone available and carried naloxone outside of work hours.

    Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in Naloxone Behavioral Outcomes in Policing Procedure

    Number of days during the past 30 days in which participants responded to an OD event, attempted to intervene, and/or administered naloxone.

    Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in Referral Behavioral Outcomes in Policing Procedure

    Number of referrals to evidence-based or other drug treatment or social services made during the past 30 days.

    Time frame: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in Confiscation Behavioral Outcomes in Policing Procedure

    Number of episodes involving syringe confiscation in the past 30 days (with/without proper technique).

    Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in Confiscation Behavioral Outcomes in Policing Procedure

    Number of episodes in the past 30 days involving drug confiscation (with/without proper technique).

    Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

Secondary Outcomes (10)

  • Change in participant knowledge about needle stick injury and treatment

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in participant knowledge about needle stick injury and treatment

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in participant knowledge about needle stick injury and treatment

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in participant knowledge about needle stick injury and treatment

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Change in participant knowledge about needle stick injury and treatment

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • +5 more secondary outcomes

Other Outcomes (10)

  • Degree of participant familiarity with fentanyl-class substances

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Degree of participant familiarity with best-practices related to policing PWUO and PWID who may be carrying heroin contaminated with fentanyl-class substances

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • Opioid-Related OD knowledge

    [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days]

  • +7 more other outcomes

Study Arms (2)

Opioids and Police Safety Occupational Risk Reduction Training

EXPERIMENTAL

Provides occupational risk reduction training for police in 49 slides including 8 filmed videos (police officers, MDs, SSP staff, a person in recovery). The training is delivered online with secure access only for enrolled study participants.

Behavioral: Opioids and Police Safety Occupational Risk Reduction Training (OPS)

COVID Occupational Risk Reduction Training

ACTIVE COMPARATOR

The COVID-19 and Police Safety training (Control only) includes 22 slides, also narrated by a professional voice narrator.

Behavioral: Opioids and Police Safety Occupational Risk Reduction Training (COVID)

Interventions

Potential participants are provided with a flyer with directions to enroll online. Groups are randomized by zip code (all participants with the same zip code receive the same training to avoid contamination by precinct) Both the experimental and control groups first take the online GetNaloxoneNow.org First Responder training; then the experimental group takes the online OPS training and the control group takes the online COVID training. Both groups take a pre-survey prior to both trainings and a post-survey after they complete both trainings. Both groups also receive (via email) a resource list with information that was provided in their respective trainings plus additional resources re: occupational risk reduction appropriate to each training. Every quarter for one year, participants are emailed a reminder to get back online to take the survey again.

Also known as: OPS
Opioids and Police Safety Occupational Risk Reduction Training

Potential participants are provided with a flyer with directions to enroll online. Groups are randomized by zip code (all participants with the same zip code receive the same training to avoid contamination by precinct) Both the experimental and control groups first take the online GetNaloxoneNow.org First Responder training; then the experimental group takes the online OPS training and the control group takes the online COVID training. Both groups take a pre-survey prior to both trainings and a post-survey after they complete both trainings. Both groups also receive (via email) a resource list with information that was provided in their respective trainings plus additional resources re: occupational risk reduction appropriate to each training. Every quarter for one year, participants are emailed a reminder to get back online to take the survey again.

Also known as: COVID
COVID Occupational Risk Reduction Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Active duty Police Officer

You may not qualify if:

  • Desk only- not active duty

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York University

New York, New York, 10010, United States

Location

Related Publications (1)

  • Simmons J, Elliott L, Bennett AS, Beletsky L, Rajan S, Anders B, Dastparvardeh N. Evaluation of an Experimental Web-based Educational Module on Opioid-related Occupational Safety Among Police Officers: Protocol for a Randomized Pragmatic Trial to Minimize Barriers to Overdose Response. JMIR Res Protoc. 2022 Feb 25;11(2):e33451. doi: 10.2196/33451.

MeSH Terms

Conditions

Opiate Overdose

Interventions

Analgesics, Opioid

Condition Hierarchy (Ancestors)

Drug OverdosePrescription Drug MisuseDrug MisuseSubstance-Related DisordersChemically-Induced DisordersOpioid-Related DisordersNarcotic-Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

NarcoticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnalgesicsSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants are randomized to the experimental or the control arm for occupational risk reduction trainings. Trainings are not designated as experimental or control. CHANGE TO PROTOCOL: Control dropped to enable recruitment. Outcome measures are the same.
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: The Opioids and Police Safety Study employed a pragmatic trial design evaluated in a simultaneous embedded mixed-method approach.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2021

First Posted

August 17, 2021

Study Start

January 22, 2021

Primary Completion

February 10, 2023

Study Completion

March 1, 2024

Last Updated

December 7, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations